Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
How can CAR-T Cell engineering overcome the remaining limitations of cell therapy? CAR-T cell engineering has become one of the most active areas of cancer immunotherapy research.
CAR-T cell therapy is an emerging alternative to conventional anticancer treatments. Over the years, these modified cells have demonstrated promising… Read More
CAR-T cells are a form of adoptive T cell therapy (ACT). This emerging technology combines the cytotoxic potential of T… Read More
Manufacturing CAR-T cells is a complex process requiring the collection of T cells from autologous or allogeneic sources and subsequent… Read More
Prompted by encouraging clinical and preclinical results, the structure of CAR-T cells has evolved rapidly to minimize off-target toxicity and… Read More